GSK Phase III Trials Show Promise for Chronic Hepatitis B Therapy
GSK plc has reported positive results from two pivotal phase III clinical trials evaluating bepirovirsen, an investigational antisense oligonucleotide therapy for chronic hepatitis B…
Read More...
Read More...
